Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
CALL
Babcock & Wilcox
BW
$849M
| $7.7M | ﹤0.01% |
523,900
+275,100
| +111% | +$2.89M |
2021 Q1
20 quarters
|
|
3602
CALL
West Pharmaceutical
WST
$25.7B
| $7.69M | ﹤0.01% |
30,700
+19,300
| +169% | +$4.8M |
2019 Q3
26 quarters
|
|
3603
PUT
uniQure
QURE
$1.63B
| $7.69M | ﹤0.01% |
470,500
-12,700
| -3% | -$257K |
2018 Q2
31 quarters
|
|
|
ARTY
3604
iShares Future AI & Tech ETF
ARTY
$4.33B
| $7.69M | ﹤0.01% |
+165,307
| New | +$8.3M |
2026 Q1
0 quarters
|
|
3605
PUT
Amkor Technology
AMKR
$13.9B
| $7.69M | ﹤0.01% |
170,800
-74,000
| -30% | -$3.55M |
2019 Q4
25 quarters
|
|
3606
Pegasystems
PEGA
$5.58B
| $7.68M | ﹤0.01% |
180,565
-56,537
| -24% | -$2.63M |
2023 Q4
9 quarters
|
|
3607
Direxion Daily MSFT Bull 2X ETF
MSFU
$550M
| $7.68M | ﹤0.01% |
333,916
+321,073
| +2,500% | +$9.79M |
2023 Q3
10 quarters
|
|
3608
CALL
Stride
LRN
$3.28B
| $7.68M | ﹤0.01% |
87,100
-58,700
| -40% | -$4.76M |
2020 Q1
24 quarters
|
|
3609
CALL
QuantumScape Corp
QS
$2.81B
| $7.67M | ﹤0.01% |
1,202,400
-3,513,900
| -75% | -$29.2M |
2020 Q3
22 quarters
|
|
3610
PUT
Archer Aviation
ACHR
$3.77B
| $7.67M | ﹤0.01% |
1,483,800
-686,500
| -32% | -$4.9M |
2021 Q3
18 quarters
|
|
|
IMSR
3611
Terrestrial Energy
IMSR
$400M
| $7.67M | ﹤0.01% |
1,277,258
-751,950
| -37% | -$5.96M |
2025 Q2
3 quarters
|
|
3612
Capital Group Core Balanced ETF
CGBL
$7.62B
| $7.66M | ﹤0.01% |
222,510
+55,052
| +33% | +$1.97M |
2024 Q4
5 quarters
|
|
3613
Sprouts Farmers Market
SFM
$6.01B
| $7.65M | ﹤0.01% |
99,236
-2,143,919
| -96% | -$160M |
2013 Q3
50 quarters
|
|
3614
Lyell Immunopharma
LYEL
$227M
| $7.65M | ﹤0.01% |
381,462
+56,761
| +17% | +$1.33M |
2022 Q4
13 quarters
|
|
|
PR
3615
PUT
Permian Resources
PR
$18.5B
| $7.65M | ﹤0.01% |
358,900
-70,200
| -16% | -$1.21M |
2018 Q2
31 quarters
|
|
3616
DNOW Inc
DNOW
$2.85B
| $7.65M | ﹤0.01% |
642,429
-1,101
| -0.2% | -$14.9K |
2022 Q4
13 quarters
|
|
|
KLAR
3617
CALL
Klarna Group
KLAR
$4.74B
| $7.65M | ﹤0.01% |
584,500
+441,500
| +309% | +$8.74M |
2025 Q3
2 quarters
|
|
3618
PUT
Madison Square Garden
MSGS
$9.8B
| $7.65M | ﹤0.01% |
23,800
-87,800
| -79% | -$26.2M |
2013 Q2
51 quarters
|
|
3619
RLJ Lodging Trust
RLJ
$1.71B
| $7.65M | ﹤0.01% |
1,030,829
+214,118
| +26% | +$1.67M |
2016 Q4
37 quarters
|
|
3620
PagSeguro Digital
PAGS
$2.49B
| $7.64M | ﹤0.01% |
762,225
+267,976
| +54% | +$2.79M |
2021 Q4
17 quarters
|
|
3621
Neurocrine Biosciences
NBIX
$14.6B
| $7.64M | ﹤0.01% |
57,968
-21,743
| -27% | -$2.88M |
2022 Q3
14 quarters
|
|
3622
Ormat Technologies
ORA
$5.71B
| $7.63M | ﹤0.01% |
68,198
-12,565
| -16% | -$1.46M |
2019 Q1
28 quarters
|
|
|
PBOG
3623
Portfolio Building Block Integrated Oil and Gas and Exploration and Production Index ETF
PBOG
$464M
| $7.62M | ﹤0.01% |
215,069
+175,807
| +448% | +$5.27M |
2025 Q4
1 quarter
|
|
3624
Autohome
ATHM
$2.37B
| $7.62M | ﹤0.01% |
438,773
+354,407
| +420% | +$7.28M |
2025 Q4
1 quarter
|
|
3625
PUT
Xenon Pharmaceuticals
XENE
$3.68B
| $7.62M | ﹤0.01% |
131,000
+84,100
| +179% | +$3.87M |
2021 Q2
19 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.